Dr. Beverly A. Teicher, Cheif of the Molecular Pharmacology Branch at the National Cancer Institute

Beverly A. Teicher, PhD is Chief of the Molecular Pharmacology Branch at the National Cancer Institute (NCI), Dr. Teicher completed a PhD in Bioorganic Chemistry at the Johns Hopkins University and postdoctoral training at Yale University School of Medicine. After positions at the Dana-Farber Cancer Institute and Harvard Medical School, Dr. Teicher served as Research Advisor in Cancer Drug Discovery at Lilly Research Laboratories and Vice President of Oncology Research at Genzyme. Dr. Teicher is best known for her work in solid tumor models and physiologic measurements of tumor hypoxia and oxygenation. She has authored or co-authored more than 400 scientific publications, edited eight books, and is editor for the journal Clinical Cancer Research, the journal Pharmacology and Therapeutics, and the Cancer Drug Discovery & Development book series.